Home » ETF » LABU

LABU - Direxion Daily S&P Biotech Bull 3x Shares

Stock Price: $64.49 USD -1.43 (-2.17%)
Updated Apr 21, 2021 9:46 AM EDT - Market open
Assets $657.27M
NAV $65.98
Expense Ratio 1.04%
PE Ratio n/a
Beta (5Y) 4.07
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 23, 2019
1-Year Return -
Trading Day April 21
Last Price $64.49
Previous Close $65.92
Change ($) -1.43
Change (%) -2.17%
Day's Open 65.30
Day's Range 63.70 - 65.79
Day's Volume 338,832
52-Week Range 32.20 - 185.61

Fund Description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index (index). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds (ETFs) that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Asset Class
Portfolio-Multi Asset
Sector
Biotech
Region
Global
Inception Date
May 28, 2015
Exchange
NYSEARCA
Ticker Symbol
LABU
Index Tracked
S&P Biotechnology Select Industry Index

Top 10 Holdings

76.51% of assets
NameSymbolWeight
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPn/a31.21%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPn/a11.60%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPn/a10.71%
S&P Biotechnology Select Industry Index SWAPn/a6.99%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPn/a5.84%
DREYFUS GOVT CASH MGMTn/a2.96%
DREYFUS GOVT CASH MGMTn/a2.74%
GOLDMAN FINL SQ TRSRY INST 506n/a1.57%
DREYFUS GOVT CASH MGMTn/a1.56%
GOLDMAN FINL SQ TRSRY INSn/a1.33%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 23, 2019$0.005Dec 31, 2019
Sep 24, 2019$0.011Oct 1, 2019
Jun 25, 2019$0.037Jul 2, 2019
Mar 19, 2019$0.11Mar 26, 2019
Dec 27, 2018$0.096Jan 4, 2019
Sep 25, 2018$0.095Oct 2, 2018
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Direxion's weekly ETF fund flows could shed light on what traders are thinking. The top three point to interest in long-term bond prices, biotech strength, and semiconductor weakness.

Other tickers mentioned: SOXS, TMV
1 week ago - ETF Trends

U.S. president Joe Biden's infrastructure plan is opening up ETF trading possibilities from multiple angles. One way is playing its healthcare component via funds like the Direxion Daily Healthcare Bull...

Other tickers mentioned: CURE
1 week ago - ETF Trends

The S&P 500, the Dow Jones, the Nasdaq Composite and the small-cap Russell 2000 were all on an uptrend last week.

Other tickers mentioned: DFEN, DPST, DRN, NVAX, RETL, TNA, URTY ...
1 month ago - Zacks Investment Research

Investors flocked to leveraged ETFs to cash in on the opportunity offered by an improving economy and a rising stock market.

Other tickers mentioned: FNGU, HIBL, RETL, SOXL, TPOR, UBOT, URTY ...
1 month ago - Zacks Investment Research

The S&P 500, the Dow Jones, the Nasdaq Composite and the small-cap Russell 2000 were all on an uptrend last week.

Other tickers mentioned: DFEN, DPST, DRN, NVAX, RETL, TNA, URTY ...
1 month ago - Zacks Investment Research

Solid corporate earnings and expectations of a fat stimulus by U.S. President Joe Biden's administration have renewed the appeal for the riskier assets last week.

Other tickers mentioned: DPST, HIBL, NRGU, TNA, URTY, USO, WEBL
2 months ago - Zacks Investment Research

The month of January was volatile for the global stock market.

Other tickers mentioned: AMC, CWEB, RETL, UVXY
2 months ago - Zacks Investment Research

The biotechnology industry isn't backing down, with ETFs like the Direxion Daily S&P Biotech Bull 3x Shares (LABU) gaining over 15% to start the new year. More strength could be ahead as the global econ...

3 months ago - ETF Trends

The S&P 500, the Nasdaq-100 and the Dow Jones gained about 3.6%, 5.9% and 3.4%, respectively, last week.

Other tickers mentioned: ACWI, BDRY, DPST, KORU, NRGU
3 months ago - Zacks Investment Research

The month of December has been kind for the stock market with the major indices enjoying a historic rally despite the surge in coronavirus cases.

Other tickers mentioned: DPST, FNGU, RETL, TNA
3 months ago - Zacks Investment Research

We highlight some leveraged ETFs that gained more than 85% over the past three months.

Other tickers mentioned: DPST, HIBL, SOXL, TNA
3 months ago - Zacks Investment Research

Traders understand that when you add leverage to the mix, the results can be explosive gains, but on the flip side, it could be losses and a blown trading account. Yahoo Finance focused on top leveraged...

Other tickers mentioned: CHAU, RETL
3 months ago - ETF Trends

This year has witnessed historic twists and turns with the largest bull market turning into a bear market in March on the coronavirus outbreak, and then marking the fastest-ever recovery.

Other tickers mentioned: CHAU, FNGU, RETL, ROM, UBOT, UGE, USD ...
4 months ago - Zacks Investment Research

Last week was downbeat for Wall Street. Still, these ETFs offered decent gains.

Other tickers mentioned: DRV, RUSL, YANG
4 months ago - Zacks Investment Research

Last week was downbeat for Wall Street. Still, these ETFs offered decent gains.

Other tickers mentioned: DRV, RUSL, YANG
4 months ago - Zacks Investment Research

The S&P 500, the Dow Jones and the Nasdaq Composite gained about 1.7%, 1.0% and 2.1%, respectively, last week.

Other tickers mentioned: HIBL, NRGU, SMHB, SOXL
4 months ago - Zacks Investment Research

The solid fundamentals and a soaring stock market have resulted in huge demand for the leveraged ETFs.

Other tickers mentioned: DFEN, HIBL, NRGU, RETL, SOXL
4 months ago - Zacks Investment Research

Growth investing will also likely to stay strong maintaining the ongoing trend.

Other tickers mentioned: CURE, CWEB, FNGU, NAIL, TQQQ, WEBL
5 months ago - Zacks Investment Research

The Covid-19 brought certain sectors serendipitous gains like technology, but even that space is now seeing sell-offs amid a September sell-off. As such, short sellers are coming in to reap the rewards,...

6 months ago - ETF Trends

It’s been a memorable, if not unusual, summer of 2020, but it’s not stopping biotech bulls from charging forward. The sector has been on a steady uptrend despite the economic effects of Covid-19.

Other tickers mentioned: IBB
8 months ago - ETF Trends

LABU: Which Biotechs Have Led the Covid Trade? Summertime is typically regarded as a notoriously choppy month for markets as volume tends to dissipate.

8 months ago - ETF Trends

As the broad market knocks on the door of all-time highs in the midst of a still-raging public health crisis, traders have had to simultaneously ride the bullish wave (in most sectors) while also modera...

Other tickers mentioned: NAIL, RETL
8 months ago - Benzinga

The month of June started with a bang, extending the two-month bull rally. The optimism over accelerating economic activities as many states reopened, a booming technology sector, an unprecedented stimu...

Other tickers mentioned: FNGU, RXD, SDP, SOXL, TECL, TQQQ
9 months ago - Zacks Investment Research

We highlighted some leveraged equity ETFs that piled up more than 100% returns in the second quarter.

Other tickers mentioned: FNGU, GUSH, NAIL, RETL, WEBL
9 months ago - Zacks Investment Research

The coronavirus pandemic is fueling gains for biotechnology exchange traded funds this year and the leverage members of this group are participating in the fun.

9 months ago - Benzinga

The easing of lockdown measures is propelling demand, leading to renewed confidence among investors.

Other tickers mentioned: FNGU, HIBL, NAIL, RETL, SOXL, UBOT, WANT ...
10 months ago - Zacks Investment Research

After a brutal first quarter, U.S. stocks strongly rebounded on an unprecedented fiscal and monetary stimulus, progress in the development of a coronavirus vaccine or treatment as well as optimism over ...

Other tickers mentioned: ERX, FNGU, GUSH, NAIL, NRGU, RETL, WEBL
11 months ago - Zacks Investment Research

These leveraged ETFs were outperformers last week.

Other tickers mentioned: DGBP, JNUG, NVAX, UCO, USLV
11 months ago - Zacks Investment Research

Oil, tech and biotech caused a rally in the leveraged ETF space last week.

Other tickers mentioned: MEXX, NAIL, NRGU, SOXL, WEBL
11 months ago - Zacks Investment Research

U.S. stocks came back roaring in April buoyed by unprecedented fiscal and monetary stimulus, progress in the development of a coronavirus vaccine or treatment as well as optimism over the reopening of t...

Other tickers mentioned: GUSH, HIBL, JNUG, NAIL, NRGU, RETL
11 months ago - Zacks Investment Research

Last week was all about ebbs and flows in oil prices that led Wall Street to snap the weekly winning streak.

Other tickers mentioned: GUSH, JNUG, TMF, WEBL
11 months ago - Zacks Investment Research

The 10 best index funds are a mix of buy-and-hold ETFs that will serve you for decades, as well as a couple tactical trading tools.

Other tickers mentioned: DUST, IJH, IVV, JNK, KBE, NUGT, PFXF ...
1 year ago - InvestorPlace

The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic.

Other tickers mentioned: CURE, PILL
1 year ago - Benzinga

The biotech and healthcare space has been on fire lately. The healthcare space is witnessing a Mergers and Acquisitions wave recently that has achieved an impressive $342 billion in new deal activity so...

Other tickers mentioned: LABD
1 year ago - ETF Trends

Discover why biotech stocks are surging despite large fund outflows. Monitor these three industry ETFs for "buy the dip" opportunities.

Other tickers mentioned: PBE, XBI
1 year ago - Investopedia

Inside the best five best leveraged ETFs of November.

Other tickers mentioned: CURE, FNGU, TECL
1 year ago - Zacks Investment Research

We have highlighted a few leveraged equity ETFs that have piled up more than 25% returns so far in the fourth quarter and could continue to be investors' darlings.

Other tickers mentioned: FNGU, SOXL, TECL, UBIO
1 year ago - Zacks Investment Research

Jablonski: Biotech presents a good buying opportunity

YouTube video

Sylvia Jablonski of Direxion discusses why biotech stocks and ETFs are attractive right now, due to their cheapness relative to the rest of the market.

Other tickers mentioned: CURE, XLV
1 year ago - CNBC Television

Trade optimism, a third Fed rate cut and some better-than-expected corporate earnings drove the stock market last week.

Other tickers mentioned: BOIL, CURE, INDL, JNUG, PILL, RUSL, UBIO ...
1 year ago - Zacks Investment Research

The U.S.-China trade war is more than 18 months old. And in that time the conflict has taken a toll on stocks across the world and put company executives and market watchers alike on edge.

Other tickers mentioned: SOXL, SOXS, LABD, TECL, TECS
1 year ago - Benzinga

Biotech stocks fall after Trump promises executive order drug prices

YouTube video

CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.

Other tickers mentioned: ARKG, FBT, FHLC, IBB, RYH, VHT, XBI ...
1 year ago - CNBC Television

With biotechnology stocks and the related exchange-traded funds recently showing some signs of life, it could be just a matter of time before aggressive traders embraced leveraged healthcare ETFs.

1 year ago - Benzinga

For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven tra...

Other tickers mentioned: CURE
1 year ago - Benzinga

When the stock market is hitting record highs, it’s important to remember that it’s really a market of stocks rather than a stock market. Not all companies are created equal. Nor are all sectors.

Other tickers mentioned: AMGN, ARKG, BBH, BIIB, BMY, CELG, FBT ...
1 year ago - 24/7 Wall Street

Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price action.

2 years ago - Benzinga

We have highlighted six leveraged equity ETFs that have piled up more than 50% returns in the first quarter.

Other tickers mentioned: CHAU, NAIL, SOXL, TECL
2 years ago - Zacks Investment Research